Chong Kun Dang Pharmaceutical Corp
KRX:185750

Watchlist Manager
Chong Kun Dang Pharmaceutical Corp Logo
Chong Kun Dang Pharmaceutical Corp
KRX:185750
Watchlist
Price: 93 300 KRW 0.65%
Market Cap: 1.2T KRW
Have any thoughts about
Chong Kun Dang Pharmaceutical Corp?
Write Note

Chong Kun Dang Pharmaceutical Corp
Investor Relations

Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-12-06. The firm is mainly involved in the production and sale of prescription drugs such as antidiabetic treatments, cerebrovascular disease treatments, hypertension treatments and hyperlipidemia therapies. In addition, the Company provides over the counter (OTC) drugs including penzal, prefermine and modcol; quasi-drugs including insecticides and hair dyes; and health functional food. The firm sells products in domestic and overseas markets.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Young-Joo Kim
President, CEO & Chairman
No Bio Available

Contacts

Address
SEOUL
Seoul
8, Chungjeong-ro, Seodaemun-gu
Contacts
+82221940300
www.ckdpharm.com